| NMUCX | RWMEX | NMUCX / RWMEX | |
| Total Expense Ratio | 2.00 | 0.61 | 328% |
| Annual Report Gross Expense Ratio | 2.00 | 0.61 | 328% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 6.331 | 4.810 | 132% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 252M | 219B | 0% |
| Annual Yield % from dividends | 0.00 | 1.16 | - |
| Returns for 1 year | 10.77 | 6.62 | 163% |
| Returns for 3 years | 15.24 | 26.66 | 57% |
| Returns for 5 years | -34.89 | 26.97 | -129% |
| Returns for 10 years | -27.92 | 77.48 | -36% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UUP | 28.17 | 0.03 | +0.11% |
| Invesco DB US Dollar Bullish | |||
| MYCI | 24.68 | -0.01 | -0.06% |
| State Street® My2029 Corporate Bond ETF | |||
| IMCG | 95.11 | -0.08 | -0.08% |
| iShares Morningstar Mid-Cap Growth ETF | |||
| DVUT | 26.45 | -0.24 | -0.88% |
| WEBs Utilities XLU Defined VolETF | |||
| BIB | 96.61 | -3.71 | -3.70% |
| ProShares Ultra Nasdaq Biotechnology | |||